Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-08

FDA Approved: MIGERGOT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MIGERGOT (ergotamine tartrate and caffeine) from Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIGERGOT (Ergotamine tartrate and caffeine)

Snippet

SUPPL AP for MIGERGOT (ERGOTAMINE TARTRATE AND CAFFEINE)